scheekat@gitam.edu
LinkedIn
Google Scholar
Scopus
ORCiD
Dr. Satyanarayana Swamy Cheekatla is an immunologist specializing in infectious immunology and autoimmunity. Dr. Cheekatla obtained his Ph.D. from SGPGIMS, Lucknow, in 2012 and then received his post-doctoral training from The University of Texas Health Science Center in Tyler, Texas, USA. The present research question Dr. cheekatla aims to address: 1. Identifying Novel Biomarkers in autoimmune diseases 2. Screening and testing Natural Products
Research Publications
- Safety Assessment of Rat Embryonic Fraction for in-vivo Regenerative Therapy. Biology Open (2024).
- Qualitative and Untargeted Volatilome Fingerprinting of Aspergillus sp. and Bulbithecium sp. by HS-SPME-GCMS and Functional Interactions. Journal of Basic Microbiology (2024).
- Alcohol enhances type 1 interferon-α production and mortality in young mice infected with Mycobacterium tuberculosis. PLoS Pathogens. 14(8):e1007174 (2018).
- IL-22-dependent pancreatic islet allograft survival in type 1 diabetic mice. Nature Communications. 2016 Dec 16;7:13896. doi: 10.1038/ncomms13896.
- Urinary CXCL-10/IP-10 and MCP-1 as markers to assess activity of lupus nephritis. Lupus. 22(6):614-23 (2013).
Ongoing Research Projects
-
Urine metabolomic studies in the differential diagnosis of Seronegative Rheumatoid Arthritis and Psoriatic Arthritis by GC-MS. (DST-SERB)
Expertise
-
Cancer Immunology
-
Tuberculosis Immunology
-
Rheumatology
-
Clinical Immunology
-
Bioprospection of Natural products
Authored Books
-
NIL
